MHC Class i alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 358: 66-70, 1992
Karlhofer, F.M.; Ribaudo, R.K.; Yokoyama, W.M.; Karlhofer, F.M.; Ribaudo, R.K.; Yokoyama, W.M.
Journal of Immunology 177(9): 5761-5765
2006
ISSN/ISBN: 0022-1767 PMID: 17056498 Document Number: 604444
Document emailed within 1 workday
Related Documents
Merluzzi, V.J.; Trail, P.A.; Last-Barney, K. 1986: Differential expression of lymphokine-activated killer cells and natural killer cells in adoptive transfer experiments utilizing fractionated bone marrow Journal of Immunology 137(8): 2425-2427Itoh, K.; Tilden, A.B.; Kumagai, K.; Balch, C.M. 1985: Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells Journal of Immunology 134(2): 802-807
Garni-Wagner, B.A.; Purohit, A.; Mathew, P.A.; Bennett, M.; Kumar, V. 1993: A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells Journal of Immunology 151(1): 60-70
Mathew, P.A.; Garni-Wagner, B.A.; Land, K.; Takashima, A.; Stoneman, E.; Bennett, M.; Kumar, V. 1993: Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells Journal of Immunology 151(10): 5328-5337
Vershinina, M.I.; Khalturina, E.O.; Patiutko, I.I.; Zabezhinskiĭ, D.A.; Titov, K.S.; Lebedinskaia, O.V.; Vorob'ev, A.A.; Kiselevskiĭ, M.V.; Kuzovlev, E.N. 2004: Characterization of lymphokine-activated killer cells obtained from the natural killers--T cells of patients with hepatic tumor lesion Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 12: 32-36
Linnemeyer, P.A.; Pollack, S.B. 1993: Prostaglandin E2-induced changes in the phenotype, morphology, and lytic activity of IL-2-activated natural killer cells Journal of Immunology 150(9): 3747-3754
Tam, M.R.; Emmons, S.L.; Pollack, S.B. 1980: Analysis and enrichment of murine natural killer cells with the fluorescence-activated cell sorter Journal of Immunology 124(2): 650-655
Erb, P.; Grogg, D.; Troxler, M.; Kennedy, M.; Fluri, M. 1990: CD4+ T cell-mediated killing of MHC class II-positive antigen-presenting cells. I. Characterization of target cell recognition by in vivo or in vitro activated CD4+ killer T cells Journal of Immunology 144(3): 790-795
Thiele, D.L.; Lipsky, P.E. 1986: Leu-Leu-OMe sensitivity of human activated killer cells: delineation of a distinct class of cytotoxic T lymphocytes capable of lysing tumor targets Journal of Immunology 137(4): 1399-1406
Melder, R.J.; Brownell, A.L.; Shoup, T.M.; Brownell, G.L.; Jain, R.K. 1993: Imaging of activated natural killer cells in mice by positron emission tomography: preferential uptake in tumors Cancer Research 53(24): 5867-5871
Torgersen, K.M.; Salcedo, M.; Vaage, J.T.; Naper, C.; Rolstad, B.; Ljunggren, H.G.; Höglund, P. 1997: Major histocompatibility complex class I-independent killing of xenogeneic targets by rat allospecific natural killer cells Transplantation 63(1): 119-123
Wolf, S.F.; Temple, P.A.; Kobayashi, M.; Young, D.; Dicig, M.; Lowe, L.; Dzialo, R.; Fitz, L.; Ferenz, C.; Hewick, R.M. 1991: Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells Journal of Immunology 146(9): 3074-3081
Shirakawa, F.; Tanaka, Y.; Eto, S.; Suzuki, H.; Yodoi, J.; Yamashita, U. 1986: Effect of interleukin 1 on the expression of interleukin 2 receptor (Tac antigen) on human natural killer cells and natural killer-like cell line (YT cells) Journal of Immunology 137(2): 551-556
Routes, J.M. 1992: IFN increases class i MHC antigen expression on adenovirus-infected human cells without inducing resistance to natural killer cell killing Journal of Immunology 149(7): 2372-2377
Sudo, T.; Aruga, A.; Shimizu, K.; Matsushita, N.; Takasaki, K. 2006: OK432-activated natural killer cells enhanced trastuzumab (Herceptin)-mediated antibody-dependent cellular cytotoxicity in patients with advanced cancer Anticancer Research 26(6b): 4327-4333
Hayakawa, K.; Salmeron, M.A.; Kornbluth, J.; Bucana, C.; Itoh, K. 1991: The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone Journal of Immunology 146(7): 2453-2460
Weil-Hillman, G.; Voss, S.D.; Fisch, P.; Schell, K.; Hank, J.A.; Sosman, J.A.; Sugamura, K.; Sondel, P.M. 1990: Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype Cancer Research 50(9): 2683-2691
Chen, M.F.; Suzuki, H.; Yano, S. 1992: Induction of murine lymphokine-activated killer-like cells by Corynebacterium parvum (C. parvum) in vitro: lysis of tumor cells and macrophages by C. parvum-induced killer cells Anticancer Research 12(2): 451-456
Andrus, L.; Atkinson, K.; Lafferty, K.J. 1982: Lethal effect of the intravenous injection of H-2 alloantigen activated T cells Clinical and Experimental Immunology 50(3): 629-634
Brooks, A.G.; Boyington, J.C.; Sun, P.D. 2000: Natural killer cell recognition of HLA class i molecules Reviews in Immunogenetics 2(3): 433-448